We report the first stage of a genome scan of schizophrenia (SZ) and bipolar disorder (BP) covering 18 candidate chromosomal areas. In addition to testing susceptibility loci that are specific to each disorder, we tested the hypothesis that some susceptibility loci might be common to both disorders. A total of 480 individuals from 21 multigenerational pedigrees of Eastern Qué bec were evaluated by means of a consensus best-estimate diagnosis made blind to diagnoses in relatives and were genotyped with 220 microsatellite markers. Two-point and multipoint model-based linkage analyses were performed and mod scores (Z, for max Z max ) are reported. The strongest linkage signals were detected at D18S1145 (in 18q12; Z = 4.03) for BP, and at D6S334 (in 6p 22-24; Z het = 3.47; ␣ = 0.66) for SZ. Three other chromosomal areas (3q, 10p, and 21q) yielded linkage signals. Chromosomes 3p, 4p, 5p, 5q, 6q, 8p, 9q, 11q, 11p, 12q, 13q, 18p and 22q showed no evidence of linkage. The 18q12 results met the Lander and Kruglyak (1995) criterion for a genome-wide significant linkage and suggested that this susceptibility region may be shared by SZ and BP. The 6p finding provided confirmatory evidence of linkage for SZ. Our results suggest that both specific and common susceptibility loci must be searched for SZ and BP. Molecular Psychiatry (2001) 6, 684-693.
Schizophrenia (SZ) and bipolar disorder (BP) are highly heritable disorders probably involving several genes and environmental factors. [1] [2] [3] Although previous linkage studies have yielded promising results for both disorders [4] [5] [6] (see Riley and McGuffin 7 and Pulver 8 for a recent comprehensive review), their results are often conflicting and difficult to interpret. Methodological obstacles to definitive findings include insufficient statistical power, unknown mode of inheritance, populational differences, uncertain phenotype definitions, 3, 9 which also complicate the comparison of results across studies. In addition, studies suggested that some susceptibility loci such as 13q32 5, 6 and 18p11 5,10 might be common to both disorders. 11, 12 As discussed elsewhere, 2, 13, 14 such common loci are compatible with previous reports of some degree of coaggregation between SZ and mood disorders. 15 In this context, as a first stage of a genome scan for SZ and BP, we prioritized chromosomal areas based on previous linkage or association results before using, in the second stage, evenly spaced (7-10 cM) markers to cover the rest of the genome which is underway. Our criteria to select candidate areas were based on previous findings of a lod score of at least 2 in the case of parametric (model-based) analyses, or a P-value of at least 0.005 in the case of non-parametric (model-free) analyses. Two other regions were investigated as follow-ups of our own preliminary findings suggesting an association between adult onset SZ and the DRD3 locus 14 and of a suggestive linkage between SZ and 11q21-q24. 16 We report here the first stage of our genome scan using 220 markers that covered approximately 30% of the genome. Some areas had to be covered more densely, because: (i) we sought to replicate previous findings and hence had to use the markers that formerly produced the most significant results; or (ii) we had to follow up positive linkage signals observed in the present study.
Methods

Sample
Families were ascertained in the Eastern Québec population of French origin with a founder effect of about 350 years. The study was approved by our University's Ethics Committee. All the subjects and family members were personally explained the study by an investigator and signed a written informed consent. Families were selected if there was at least one first-degree relative affected with the same disorder as the proband, and if there were at least four affected individuals with the same disorder. We selected 21 families: six had 30-50 members, five had 20-29, seven had 10-20 and only three had less than 10 family members. The families had an average number of six members affected by SZ or BP. Altogether, DNA was available from 480 family members. Forty-seven deceased ancestors for whom a diagnosis could be made, but from whom DNA was not available, were also included in the linkage analyses.
Diagnostic methods
The diagnostic methods and their reliability have been previously described in detail. 17, 18 Briefly, information from an interview with the subjects (using the Structured Clinical Interview for DSM-III-R), from relatives and medical records, was gathered. Based on this information, a first best-estimate DSM-III-R diagnosis (BED) was derived by the field team, unblind to diagnoses in relatives. Then, another BED was derived by a panel of four research psychiatrists who were blind to diagnoses in relatives and blind to the diagnoses made by the field team. 17, 18 We used blind BED in this study since it is generally considered to be the gold standard.
Phenotype definitions
The narrow SZ phenotype was restricted to SZ diagnosis (n = 71), and the broad SZ phenotype included SZ, schizophreniform and schizotypal personality disorders (n = 81). The narrow BP phenotype was restricted to BP I (n = 48) and the broad BP phenotype included BP I, BP II and recurrent major depression (n = 72). In addition, to test the hypothesis that some susceptibility loci may be common to SZ and BP, we used common locus (CL) phenotype definitions: the narrow CL phenotype included SZ, BP I and schizoaffective disorder (SAD) (n = 134) while the broad CL phenotype included the CL narrow, plus recurrent major depression, schizophreniform and schizotypal personality disorders (n = 169). Schizoaffective disorder (SAD) was excluded from the SZ and the BP phenotype definitions given that family studies yielded ambiguous results concerning its co-agregation with SZ and BP. However, SAD was included in the CL phenotype.
Seventeen subjects included in the present linkage analyses had a comorbid diagnosis: three had a substance abuse, nine had an alcohol dependence and five presented another diagnosis (simple phobia n = 1; panic disorder n = 2; delusional disorder n = 1; unspecified depression n = 1). In the best-estimate procedure reviewing the criteria of all potential DSM-III-R diagnoses for one subject: (i) substance or alcohol use or dependence had not to initiate or maintain the SZ or BP or spectrum disorder (as indicated in DSM-III-R); (ii) when a doubt remained present in the opinion of the panel of research psychiatrists, the level of cerMolecular Psychiatry tainty on primary diagnosis was decreased and a differential penetrance was given accordingly in linkage analysis; and finally (iii) subjects presenting the above diagnoses alone (but not a diagnosis included in the narrow and broad SZ and BP phenotypes) were classified as unaffected in the linkage analysis.
The sample consisted of seven SZ pedigrees (no more than 15% of members affected by a BP spectrum disorder), six BP pedigrees (no more than 15% affected by a SZ spectrum disorder) and eight mixed pedigrees, ie affected almost equally by both major psychoses. Such a rate of mixed pedigrees probably results from our using a blind BED since we previously reported 17, 18 that unblind diagnoses tended to be more in continuity with the most predominant diagnosis of the pedigree more frequently than blind diagnoses. The SZ phenotypes were analyzed in the SZ and mixed pedigrees, the BP phenotypes in the BP and mixed pedigrees and finally the CL phenotypes were analyzed in all families.
The mean age of onset was 25.4 (±8.5) years for SZ and 28.8 (±10.3) years for BP. The mean current age was respectively 43.8 years and 56.4 years. Males constituted 46% of the broad CL phenotype definition.
Genotyping
Genotyping was performed essentially according to Maziade et al, 14 using MapPairs primers purchased from Research Genetics (Huntsville, AL, USA). Briefly, PCR amplification of polymorphic alleles was done in the presence of 100 ng of high molecular weight genomic DNA isolated from Epstein-Barr virus-immortalized B-lymphocyte cell lines, [ 32 P]-5Ј-end-labeled primers, and Taq DNA polymerase. Samples were denatured for 2 min at 94°C and submitted to 24 amplification cycles of denaturation of 30 s at 94°C, annealing of 30 s at 49-64°C (temperature optimized for each pair of primers), and extension at 72°C for 30 s. The electrophoresis of PCR-amplified samples was conducted on 7% denaturing polyacrylamide-urea sequencing gels, in parallel with samples from normal controls or CEPH individuals 1331-01 and 1331-02 for allele identification and a pUC19 sequencing ladder for allele size determination. The autoradiograms were read by two investigators, independently and blind to the phenotypes. Linkage analysis was restricted to loci for which more than 95% of the genotypes were readable.
The data pertinent to the information content or the relative map positions of the genotyped microsatellite loci were extracted from either the Genome Database (GDB), the Cooperative Human Linkage Center (CHLC), or the Center for Medical Genetics of the Marshfield Medical Research Foundation (CMGMF).
Linkage analyses
Model-based (or parametric) linkage analyses were performed given growing evidence that they are more powerful than model-free (or non-parametric) analyses 19 even when the mode of inheritance specified is only approximately correct, provided that at least one dominant and one recessive model are considered. 20 Two-point and three-point lod scores were systematically computed using the FASTLINK version of the LINKAGE programs. 21 We modeled a disease gene with reduced penetrance. The dominant model assumed a disease allele frequency of 0.01, a cumulative penetrance at high age of 0.70, and a phenocopy rate of 0.20. The parameter values for the recessive model were respectively 0.10, 0.70 and 0.10. Both models specified age-dependent penetrances and took into account the certainty of diagnosis by increasing the phenocopy rate in liability classes corresponding to probable and possible diagnoses, as suggested by Ott.
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The analysis was first carried out using both affected and unaffected subjects, then using affected-only to reduce the impact of a misspecification in the penetrance parameter.
For each of our three diagnostic classes (SZ, BP and CL), we obtained a mod score by maximizing the maximum lod score (termed Z max ; maximized over the recombination fraction) over the eight possible combinations resulting from using two affection status (narrow vs broad), two models of transmission (dominant vs recessive) and two types of analyses (affected-unaffected vs affected-only). This means that for a given marker, 24 Z max were calculated (three disease classes × eight combinations). Although using a mod score approach yields a greater power to detect linkage than using a single model, 23 it will inevitably inflate the rate of type I error. Hence, although we relied mainly on Lander & Kruglyak's 24 Z criteria to assess the genome-wide significance level, we also corrected for multiple testing. To do so, we raised our Z criteria for level of significance by 0.70, following the guidelines of Hodge et al, 25 which is rather conservative since the 24 analyses were not all independent due to the considerable overlap in phenotype definitions. Therefore, our adjusted Z criteria were 4.0 for a significant linkage, 2.6 for a suggestive linkage, and we used 1.9 for a confirmatory linkage only in regions where 'significant' linkage was previously reported (Lander and Kruglyak criterion). 24 Three-point analyses were systematically performed using pairs of adjacent markers, according to the CMGMF sex-averaged map. Hence, each marker was included in two three-point analyses, one for each flanking marker. We restricted the analysis to two marker loci (plus the trait locus) for three reasons: (i) the three-point strategy was judged appropriate to meet the required assumptions in multipoint analyses regarding the exactness of intermarker distances and the absence of interference; 26 (ii) the degree of polymorphism provided by a pair of markers was high; (iii) we chose to preserve the large structure of our pedigrees rather than breaking it and sacrificing pedigree information in favor of marker information. Linkage analyses under the assumption of heterogeneity were performed using the admixture model implemented in the HOMOG program 27 for the two-point and threepoint mod scores exceeding our 1.9 threshold for confirmatory linkage.
Power was assessed by simulations with SLINK and MSIM. Assuming genetic homogeneity and a recombination fraction of 0.05, the expected lod scores ranged from 14.7 to 21.1 and power ranged from 96.5% to 99% depending on the phenotype definition and the mode of inheritance used. Assuming a recombination fraction () of 0.05 and a proportion of linked families (␣) of 0.7, the expected lod scores under genetic heterogeneity (ELOD het ) ranged from 4.8 to 11.9 and power ranged from 69% to 97%. The ELOD het and power for = 0.05 and ␣ = 0.5, ranged respectively from 3.05 to 7.36 and from 42% to 75%.
Results
The two-point mod score curves for each diagnostic hierarchy (SZ, BP and CL) are shown in Figure 1, providing the level of affection (either narrow or broad) for which the highest mod score was obtained for a given chromosome. The results meeting our criterion for confirmatory linkage (Z Х 1.9) either in two-point or three-point analysis are reported in Table 1 , along with the corresponding mod score found under heterogeneity (Z het ). When several markers within 25 cM met this criterion for the same phenotype definition, only the marker showing the strongest result was included in Table 1 as an attempt to obtain a set of independent results.
The strongest linkage signal was detected at D18S1145 (in 18q12; Z = 4.03, = 0.15) with the broad BP phenotype (Table 1) and there was no evidence for heterogeneity. This result met the criterion for a genome-wide significant linkage. The corresponding threepoint results that involved D18S1145 and a flanking marker each on the centromeric and telomeric side were respectively 3.39 and 3.59. Figure 2 shows the two-point results obtained on chromosome 18. One can observe that at D18S472, a marker 7.5 cM telomeric to D18S1145, a mod score of 2.81 suggested linkage with the narrow SZ phenotype (Table 1) . Again, there was no evidence for heterogeneity, and the three-point analysis involving D18S455 and D18S472 raised the evidence to 2.98, locating the disease gene 10 cM centromeric to D18S472. It is then not surprising to find, in the same region (D18S472), some evidence for linkage (Z = 2.52, = 0.10) with the CL narrow phenotype ( Figure 2 and Table 1 ), which includes SZ and BP. A few other markers in Figure 2 showed mod scores of at least 1.9 (eg D18S456 and D18S51) that were interpreted as being the echo of the above findings.
At D6S334, we found a suggestive linkage with the narrow SZ phenotype (Z = 2.82, = 0.10) ( Table 1) . Allowing for heterogeneity increased the evidence to 3.47 ( = 0; 66% of linked families). The test for heterogeneity given linkage was nearly significant at the 0.05 level ( 2 = 3.0, df = 1, P = 0.08). Although six of the eight loci (D6S259, D6S89, D6S260, D6S469, D6S1605, D6S274) located within ±5 cM of D6S334 had a mod score greater than 1.0 (Figure 1) , the three-point analyses tended to decrease the evidence (Z = 1.69 and 1.99). Despite this decrease in significance level, the three- point lod scores may still be interpreted as a confirmatory linkage given previous linkage results in the same region (6p22-p24) for SZ. 28, 29 Three other regions provided some evidence for linkage (Z Ն 1.9) according to the two-point analyses (Table 1) : 3q13 for the narrow SZ phenotype (D3S1579; Z = 1.91, = 0.05), 10p11-p14 for the broad SZ phenotype (D10S245; Z = 2.06, = 0.15), and 21q22 for the narrow BP phenotype (Z = 2.03, = 0.15). In each case, the three-point analyses diminished the evidence.
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None of these three areas yielded significant evidence for heterogeneity. Finally, Table 1 included a single three-point result that was not detected in two-point analyses. Indeed, markers D10S2325 and D10S674 did not show support for linkage with the narrow BP phenotype when analyzed individually, but taken together, they yielded a mod score of 2.44 that reached our criterion for confirmatory linkage, locating the disease gene on D10S674. The analysis under heterogeneity did not increase the evidence. Figure 1 shows that several chromosomal regions tested in our study did not yield results that met our criteria for significant, suggestive or confirmatory linkage, although a peak at D13S779 observed for the SZ, BP, and CL phenotypes coincided with the results for SZ reported in Blouin. 
Discussion
The 18q finding and the common gene hypothesis
The two-point linkage result between the broad BP phenotype and D18S1145 (18q) met our conservative genome-wide threshold for significant linkage. In three-point analyses, the level of statistical significance decreased slightly but remained suggestive of linkage. This decrease may suggest that the two-point lodscores have been slightly inflated due to ambiguity of 'within family' marker information, or that three-point analyses underestimated the true level of significance due to their sensitivity to diagnosis misclassification and misspecification in the mode of inheritance. 30 In addition to the D18S1145 finding for BP, we obtained suggestive evidence for linkage between the narrow SZ phenotype and D18S472 located at only 7.5 cM from D18S1145. The D18S472 locus congruently yielded suggestive linkage evidence for the CL phenotype including the SZ and the BP phenotypes. Figure 2 shows that, in 18q, our results suggest linkage for either the SZ, the BP or the CL phenotypes over a 50 cM area. This phenotype pattern contrasted, for instance, with the 6p finding ( Figure 1 and Table 1) for which only the SZ phenotype was involved. One interpretation for this pattern would be that it reflects the presence of two closely located susceptibility loci on 18q, one for SZ and the other for BP. This interpretation is supported by the fact that these two linkage findings were obtained with different phenotype definitions, and by the fact that the statistical evidence for linkage using the CL phenotype was relatively weaker than that obtained with either the SZ or the BP phenotype. Another interpretation could be that these two linkages reflect the presence of a locus increasing the risk for both SZ and BP. The latter hypothesis is supported firstly by the fact that the linkage result at D18S472 using the CL phenotype met the criteria for a genome-wide suggestive linkage, secondly by the proximity of the two peaks in linkage evidence, and thirdly, by the recent simulation studies using a large number of small families 31 that suggested considerable variability in location estimates in linkage findings for complex disorders, although the latter simulations may not directly apply to the nature of our sample.
Previous evidence for linkage signals was reported for both SZ and BP on nearby areas of chromosome 18, as shown on Figure 2 . Indeed, Detera-Wadleigh et al 5 recently reported strong evidence for linkage between 18p11.2 markers and BP and Schwab et al 10 have reported linkage between SZ and markers located in the same area, which is located 20 cM centromeric to D18S1145. Stine et al 32 also reported a linkage for paternal BP and unipolar pedigrees in an area 10 cM telomeric to D18S472. Although these areas potentially linked to SZ or BP in previous studies do not fully
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overlap with the present results, the difficulty in exactly locating susceptibility loci using linkage analyses with complex disorders 30, 31 does not exclude that these findings may be compatible with ours. However, some strong and recent studies had negative results for chromosome 18 in SZ 4, 6, 33, 34 and for BP. 35 Differences among samples in terms of racial and ethnic characteristics and in terms of diagnostic procedure might explain different results across studies. For instance, the latter negative studies on 6p used SZ plus SZA as phenotypes, 4, 6, 34 or used schizophrenia related psychoses, 33 and some used DSM-III-R diagnoses whereas others used DSM-IV criteria.
In conclusion, the possibilities that more than one susceptibility locus is present in chromosome 18 and that some susceptibility loci increase susceptibility to both major psychoses, justify further investigation of chromosome 18q11-q21 while giving phenotype definition careful attention in the design of these followup studies.
2
The 6p22-p24 finding and SZ We obtained at D6S334, using a narrow SZ definition, a mod score of 2.82 under homogeneity and 3.47 under heterogeneity, which met our stringent criterion for suggestive linkage. This result was supported by flanking markers, namely D6S260 and D6S469, that produced mod scores greater than 1.9. Again, as happened for our D18S1145 finding, the evidence for linkage using three-point analyses was somewhat weaker, and this may be due to the factors formerly discussed for D18S1145. Nonetheless, these three-point results reached our criterion for confirmatory linkage, which is probably the appropriate criterion given the previous strong evidence for a susceptibility locus to SZ in 6p22-p24. 14, 28, 29 A meta-analysis of 6p findings in SZ For each marker, the maximum mod score is indicated in bold. yielded the strongest evidence of linkage for two loci (D6S274 and D6S285) that are located less than 3 cM away from D6S334 which yielded our strongest linkage result. Negative results have also been published in 6p22-24, 4,6,33,37,38 but such negative results are to be expected given the complex inheritance, the heterogeneity of SZ and differences across studies in terms of diagnostic or analytic methods. In sum, the present linkage results provide confirmatory evidence for a susceptibility locus to SZ in the 6p22-p24 area. We previously reported a preliminary linkage signal at this locus, with the CL phenotype, in a single mixed pedigree (No. 151) of our sample with a lod of 2.49 and 2.15 with markers near D6S334 (D6S296, D6S277), whereas the total maximum lod score in the whole sample was 0.00.
14 At the time, the sample was smaller (n = 354; 18 pedigrees) whereas our sample size has now reached 480 (21 pedigrees). Since then pedigree Molecular Psychiatry 151 had six new affected and unaffected family members enrolled and 47 affected subjects were added in the present sample. Now, at the D6S334 locus, and with the SZ phenotype, we have eight families presenting positive mod scores participating in the present total mod scores of 2.82 and 3.47. With the CL phenotype, the total mod score was zero, but pedigree 151 kept a Z = 1.71 at the D6S296 locus.
The chromosomes 3q, 10p and 21q
We observed a two-point mod score of 1.9 under a narrow SZ definition with D3S1579, but the evidence weakened using three-point analyses. This locus lies in the vicinity of DRD3 (3q13.3). A recent meta-analysis has suggested that the Ser9Gly polymorphism of DRD3 may be associated with SZ. 39 A significant excess of homozygosity has been observed in some studies, 39 an association we also reported for adult-onset SZ in com-parison to childhood onset SZ. 40 Our former finding, 40 the proximity between the DRD3 and the D3S1579 loci and the linkage signal observed in the present study suggest the involvement of the DRD3 locus in the etiology of SZ. Using the broad SZ phenotype, we observed a mod score of 2.06 ( = 0.15) at D10S245, which increased to 2.41 ( = 0.10) under genetic heterogeneity. Again, three-point analyses yielded lower mod scores. In addition, using the narrow BP phenotype, three-point analyses yielded a mod score of 2.44 at D10S2325 which is 10 cM apart from D10S245. Other groups reported linkage with SZ in 10p11-p14 41-43 but we found no previous reports of linkage signals for BP in this area. Therefore, the two-point mod scores presently observed at 10p11-p14 appear in agreement with these previous reports for SZ, but caution is required in the interpretation, given the low magnitude of linkage signals and the phenotype uncertainty about a potential linkage to SZ, to BP or to both.
We observed a mod score of 2.03 at D21S1893 using the narrow BP phenotype, and as shown in Figure 1 , other markers in this area yielded consistent results. Detera-Wadleigh et al 5 and Straub et al 44 reported a linkage signal for BP in this area. More recently, Aita et al 45 found evidence for linkage with this marker, but they reported lod scores of 2.76 under homogeneity, and 3.35 under heterogeneity with D21S1260, which is located 3 cM from D21S1893. Our results add to the evidence suggesting that a susceptibility locus to BP may be located on 21q22.
As recently suggested by the genome scans of others 5, 6 and by our previous report, 14 the present findings call for the investigation of susceptibility loci that could overlap BP and SZ, in addition to loci that would be specific to each. Also, our results, together with those of Brzustowicz et al, 4 suggest that model-based analyses using well-characterized multigenerational pedigrees are an efficient strategy to locate genes of susceptibility to major psychoses.
Further steps are now being undertaken to cover more densely some of these chromosomal regions, to finish stage-two of our genome-wide scan, and to replicate the findings in a new, and recently gathered, confirmatory sample of multigenerational pedigrees from Eastern Québec.
